SV Health Investors' Dementia Discovery Fund (DDF) Company Profile, Contacts & Intelligence

Venture Capital And Private Equity PrincipalsLondon, City of, United Kingdom30 employeesFounded 2015
2 contacts with email or phone data2 with email data1 with phone data
View verified contacts Compare competitors
Employees
30
Company source estimate
Reachable Contacts
2
Visible contacts with email or phone data
Contacts With Email
2
2 of 4 visible contacts

SV Health Investors' Dementia Discovery Fund (DDF) Overview

SV Health Investors’ Dementia Discovery Fund (DDF) is the world’s largest family of specialized venture capital funds that invests exclusively in companies developing or enabling novel therapeutics for dementia. Dementias including Alzheimer’s Disease are arguably the largest unmet medical need with over 55m patients worldwide. With more than $550m raised for this strategy, and offices in London and Boston, DDF capitalizes on global investment opportunities to fulfill its dual mandate of delivering measurable impact and generating significant financial returns. Utilizing its network of venture partners, entrepreneurs, leading scientists, and strategic partners, DDF invests in and creates new biotech companies and provides thought leadership in the field. DDF is enabled by its limited partners including major pharmaceutical companies (Biogen, Bristol Myers Squibb, Eli Lilly and Co., GSK, Johnson & Johnson, Otsuka (Astex), Pfizer and Takeda), along with AARP, Aegon, British Business Bank, Gates Frontier, gradiant, UnitedHealth Group, and the non-profits the Alzheimer’s Association, Alzheimer’s Research UK and LifeArc. Learn more at https://www.svhealthinvestors.com/ddf

Headquarters
London, City of, United Kingdom
Website
theddfund.com
Industry
Venture Capital And Private Equity Principals
Founded
2015
NAICS
Miscellaneous Intermediation
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads
Dementia Venture Capital neurodegenerative diseases Alzheimer's

SV Health Investors' Dementia Discovery Fund (DDF) Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

2 contacts with contact data
2 with email data and 1 with phone data in the visible sample.

SV Health Investors' Dementia Discovery Fund (DDF) People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

D
Dirk Landgraf
Principal at Sv Health Investors
EP
B
Barbara T.
Chief Scientific Officer
D
Damian Crowther
Developing Therapies
L
Laurence Barker
E

SV Health Investors' Dementia Discovery Fund (DDF) Workforce Composition

Seniority breakdown across 5 visible profiles.

Individual contributor
3
Executive
1
Senior / Lead
1

Compare Similar Companies to SV Health Investors' Dementia Discovery Fund (DDF)

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
SV Health Investors Venture Capital And Private Equity Principals 114 View company
AviadoBio Biotechnology Research 77 View company
Alzheimer's Drug Discovery Foundation Research Services 71 View company
Cambridge Innovation Capital Venture Capital And Private Equity Principals 35 View company
Two Bear Capital Venture Capital And Private Equity Principals 33 View company
Montara Therapeutics, Inc. Biotechnology Research 20 View company
KdT Ventures Venture Capital And Private Equity Principals 17 View company
TRIMTECH Therapeutics Limited Biotechnology Research 15 View company
Dolby Family Ventures Venture Capital And Private Equity Principals 10 View company
Endlyz Therapeutics Biotechnology Research 7 View company